日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語(yǔ)Fran?ais
China
Home / China / National affairs

Vaccine makers may face harsh penalties for legal violations

By WANG XIAODONG | China Daily | Updated: 2018-11-13 07:45
Share
Share - WeChat
[Photo/VCG]

Vaccine producers could be given harsh penalties for a range of violations, with substantial fines possible, under a new draft law from China's top market regulator after a major quality control scandal earlier this year.

Serious violators could have profits confiscated, certificates revoked, production suspended and face fines of up to 10 times the value of the products in question.

Violations under scrutiny include falsifying manufacturing records and failing to recall products sold after quality issues or other potential safety risks were discovered, according to the draft.

Senior executives and other employees at key posts within offending companies will have their salaries recalled during periods of infraction, and may be required to pay an additional fine of between 50 and 100 percent of their pay. They may be banned from engaging in pharmaceutical activities for life, according to the draft.

The draft was released by the State Administration for Market Regulation on its website and is soliciting public opinion and feedback until Nov 25.

Almost all existing laws were drafted by government departments before they were submitted to legislators for consideration.

Producers of substandard drugs could have their illegal gains confiscated and pay fines of up to three times the value of the products involved, according to the existing Drug Management Law, which covers vaccines and is now undergoing revision.

The draft, once made into law, will prioritize the Drug Management Law and other related laws in the management of vaccines, according to the administration.

Vaccine producers could have their illegal gains confiscated and production suspended, and they would face fines of up to 1 million yuan ($143,000) for violations such as refusing to take effective measures to recall problematical products sold on the market, the draft said.

Vaccine producers must purchase insurance in case they are faced with compensation for substandard products, it said.

"Vaccines relate to people's life and health, public health and national security," the administration said in a statement.

The draft was made in response to public concern over improving supervision of vaccines, and is meant to eliminate loopholes exposed by the case involving Changchun Changsheng Bio-tech Co, it said.

The rabies vaccine producer, based in Changchun, Jilin province, was found to have falsified production records during an unannounced inspection in July by China's top drug authority.

An investigation team announced in August the company had committed other serious violations such as using expired raw materials.

Rabies is almost always fatal if untreated. No injuries or deaths caused by the substandard rabies vaccines produced by the company have been publicly reported so far.

Tao Lina, a Shanghai-based public health expert, said the punitive measures stipulated in the draft will help deter vaccine producers and sellers from violating laws. But how to effectively uncover such violations remains a problem.

"A system that financially rewards whistlerblowers should be established to encourage insiders to report law violations," he said.

Wang Yuedan, a professor of immunology at Peking University, said requiring vaccine producers to buy insurance will ensure compensation for those receiving vaccinations if serious side effects occur, and encourage vaccinations among the public.

"Although many regulations stipulated in the draft have in practice been carried out, they will be better implemented once they become law," he said.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 亚洲精品一区二区三区不 | 免费啪视频在线观看免费的 | 久草手机视频在线观看 | 日韩中文字幕av | 国产亚洲精品久久久久久线投注 | 欧美日韩三级在线观看 | 奇米视频7777 | 欧美高清在线精品一区二区不卡 | 一级片黄色免费 | 日本高清高色 | 日韩在线短视频 | 天天色播 | 福利视频在线免费观看 | 奇米777四色成人影视 | 国产精品尤物 | 亚洲一区二区三区四区五区中文 | 俄罗斯hdxxx 亚洲欧美视频在线播放 | 99青草青草久热精品视频 | 精品国产青草久久久久福利 | 精品欧美乱码久久久久久 | 青青草最新网址 | 影音先锋亚洲资源 | 欧美a性| 四虎影视永久免费观看网址 | 91综合视频| 国产精品综合亚洲AV久久久小说 | 日韩影视在线 | 免费国产一区二区在免费观看 | 丝袜 亚洲 另类 欧美 变态 | 免费二区 | 激情六月综合 | 日本高清色视频在线观看免费 | 苏晓晖个人简介军衔 | 成人免费高清 | 夜夜视频 | 久久久国产精品福利免费 | 91毛片网 | 天天色天天射天天干 | 亚洲第一区精品观看 | 成人黄色毛片 | 久久亚洲精品国产一区 |